Cipla Launches Yurpeak, a Once-Weekly Injectable Therapy for Obesity and Diabetes
Cipla Limited (BSE: 500087; NSE: CIPLA; and hereafter referred to as “Cipla”) has announced the launch of Yurpeak® (tirzepatide), a one-weekly injectable therapy for managing obesity and type 2 diabetes…
